SNWV
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E 50.27, Graham Number $1.32
- Price is 15x the Graham Number
- P/B ratio of 109.63 is unsustainable
- P/E of 50.27 is high given the debt profile
Ref Growth rates and Forward P/E
- Strong YoY revenue growth of 26.8%
- Forward P/E of -2061.00 suggests a collapse in expected earnings
Ref Historical price trends
- 5-year growth of 58.2%
- 1-year return of -31.2%
- 6-month return of -39.3%
Ref Piotroski F-Score and Debt/Equity
- Current ratio of 1.38 provides minimal liquidity
- Piotroski F-Score 3/9 (Weak)
- Debt/Equity 14.19 is critically high
Ref Yield, Payout
- No dividend payments
- 0% payout ratio
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SNWV and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SNWV
SANUWAVE Health, Inc.
Primary
|
+58.2% | +58.2% | -31.2% | -39.3% | -2.2% | +22.4% |
|
LFCR
Lifecore Biomedical, Inc.
Peer
|
-52.8% | +24.4% | -17.0% | -26.9% | -30.2% | +23.7% |
|
KPTI
Karyopharm Therapeutics Inc.
Peer
|
-94.7% | -87.2% | +100.5% | +45.5% | -8.6% | +35.8% |
|
INGN
Inogen, Inc.
Peer
|
-88.6% | -52.4% | -10.6% | -22.4% | +1.6% | +1.9% |
|
NNOX
Nano-X Imaging Ltd.
Peer
|
-92.8% | -63.4% | -47.9% | -40.0% | -4.6% | +7.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SNWV
SANUWAVE Health, Inc.
|
BEARISH | $177.13M | 50.27 | -% | 26.8% | $20.61 | |
|
LFCR
Lifecore Biomedical, Inc.
|
BEARISH | $178.02M | - | -% | -23.8% | $4.75 | Compare |
|
KPTI
Karyopharm Therapeutics Inc.
|
BEARISH | $180.35M | - | -% | -134.2% | $8.0 | Compare |
|
INGN
Inogen, Inc.
|
BEARISH | $172.38M | - | -12.4% | -6.5% | $6.33 | Compare |
|
NNOX
Nano-X Imaging Ltd.
|
BEARISH | $171.89M | - | -34.8% | -% | $2.47 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | MANCHESTER MANAGEMENT CO L L C | Divisional Officer | Sale | 20,000 | $627,092 |
| 2025-12-10 | MANCHESTER MANAGEMENT CO L L C | Affiliated Person | Sale | 144,810 | $4,450,061 |
| 2025-12-10 | MANCHESTER MANAGEMENT COMPANY, LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | 144,810 | $4,450,061 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning SNWV from our newsroom.